Oliver Kurucz
Rheumatology · Easton, PANPI 1821159203
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $303,344 of the $372,978 with a category attached, or 81.3%. Amgen accounts for 79.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $91,811 and has fallen 58.6% since, to $37,986 in 2025. Among rheumatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 507 payments — averaging $735.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$298K
- Bristol Myers Squibb$64K
- UCB, Inc.$6K
- Medexus Pharma, Inc.$4K
- AstraZeneca$310
- AbbVie$292
- plus $425 from 7 others
What the payments were for
- Consulting fees$14,7084%
- Speaking & faculty fees$303,34481%
- Travel & lodging$40,80011%
- Food & beverage$14,0254%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 335 | $297,633 |
| Bristol Myers Squibb | 101 | $63,960 |
| UCB, Inc. | 36 | $6,189 |
| Medexus Pharma, Inc. | 8 | $4,169 |
| AstraZeneca | 6 | $310 |
| AbbVie | 5 | $292 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Genentech USA, Inc. | 5 | $123 |
| Novartis | 4 | $72 |
| Pfizer | 3 | $52 |
| Boehringer Ingelheim | 1 | $22 |
| GSK | 1 | $20 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$372,978 in reported general payments places this provider in the 95th percentile of 351 rheumatology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 27 | $593 |
| Prednisone | 22 | $234 |
| Hydroxychloroquine Sulfate | 11 | $194 |
| Allopurinol | 22 | $139 |
| Alendronate Sodium | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Easton
- Alan EpsteinPhiladelphia$1.2M
- Lawrence LeventhalHuntingdon Valley$1.1M
- Alan KivitzDuncansville$936K
- Paula HerringNewtown Square$920K
- Rohit AggarwalPittsburgh$810K
- Frederick MurphyDuncansville$494K
- Peter MerkelRadnor$479K
- Martin BergmanRidley Park$458K
- Alexis Ogdie-BeattyPhiladelphia$433K
- Ellen FieldBethlehem$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.